Frontline ICI-Based Combination Therapy in Patients With Metastatic RCC With Poor Performance Status
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status
Eur. J. Cancer 2023 Feb 01;180(xx)21-29, L Carril-Ajuria, E Colomba, C Romero-Ferreiro, L Cerbone, R Ratta, P Barthelemy, C Vindry, A Fléchon, F Cherifi, E Boughalem, C Linassier, G Fornarini, SE Rebuzzi, M Gross-Goupil, C Saldana, M Martin-Soberón, G de Velasco, R Manneh, C Pernaut, A Sanchez de Torre, R Flippot, B Escudier, L AlbigesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.